Clinical trial
Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not…
NCT00475410 · Tigenix S.A.U., Industry · Completed
Key facts
| NCT number | NCT00475410 |
|---|---|
| Title | Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease |
| Official title | A Phase III Multicenter, Single Blind, Randomized, Comparative and add-on Clinical Trial, in Three Parallel Groups, to Evaluate Efficacy and Safety of a New Therapy With Adipose-derived Autologous Stem Cells for the Treatment of Complex Perianal Fistulas in Patients Without Inflammatory Bowel… |
| Acronym | FATT1 |
| Lead sponsor | Tigenix S.A.U., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anal Fistula |
| Intervention type | Drug |
| Interventions | ASCs (Cx401, company code), Fibrin adhesive |
| Enrollment | 214 |
| Start date | Feb 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | May 21, 2007 |
| Last update posted | Apr 12, 2019 |
| Countries | Germany, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: